Genomic characterisation identifies cross-border importation of the 2026 Bundibugyo virus outbreak lineage from the Democratic Republic of the Congo into Kenya

Viruses are constantly changing their genetic code, a process that leaves a unique trail of mutations as they spread from person to person and place to place. Scientists who study these changes, known as genomic surveillance, can read this trail to understand where an outbreak began, how it moves, and whether it is a new local threat or an arrival from elsewhere. This field is crucial for public health because knowing the origin of a disease allows authorities to target their response effectively, rather than guessing. One such virus, the Bundibugyo virus, is a rare cause of Ebola disease in humans. Unlike its more famous relatives, for which vaccines exist, there are currently no approved vaccines or specific medicines for this particular virus. When it appears, it relies entirely on rapid detection and containment to stop its spread.

In 2026, a significant outbreak of this virus erupted in the Democratic Republic of the Congo, eventually spreading to neighboring Uganda and prompting international health alerts. As the situation developed, health officials in Kenya, a country with close ties to the affected regions, remained on high alert. In early October of that year, a patient in Kenya arrived at a hospital with a fever and a history of recent travel to the Democratic Republic of the Congo. The medical team tested the patient and confirmed the presence of the Bundibugyo virus. This discovery raised an immediate and critical question: was this a new, independent outbreak starting within Kenya, or was it a case of the virus crossing the border from the ongoing crisis next door?

To answer this, researchers at the Kenya National Public Health Institute and their international partners extracted the full genetic code of the virus from the patient's sample. They used advanced sequencing technology to read the entire genome, which is the complete set of instructions the virus uses to replicate. The resulting genetic map contained nearly 19,000 individual building blocks, known as nucleotides. The team then compared this Kenyan genetic code against a massive database of over 1,000 other virus samples collected during the 2026 outbreak in the Democratic Republic of the Congo and Uganda, as well as historical samples from previous outbreaks in 2007 and 2012.

The comparison revealed a clear and definitive story. The virus found in Kenya was not a new, local strain. Instead, its genetic code was almost identical to the strains circulating in the Democratic Republic of the Congo at that time. In fact, the Kenyan sample differed from its closest relatives in the Congolese outbreak by only four tiny changes in its genetic code. By contrast, it was significantly different from the older outbreaks in Uganda and the Democratic Republic of the Congo from over a decade ago. This genetic closeness strongly indicates that the virus did not emerge spontaneously in Kenya. Rather, the data shows that the patient carried the virus across the border from the Democratic Republic of the Congo, where the outbreak was already well underway.

The researchers also looked for signs that the virus had been hiding in Kenya for a long time before being detected, which would have suggested a hidden local chain of transmission. They found no evidence of this. The virus's genetic makeup fit perfectly into the family tree of the 2026 outbreak, sitting within a group of samples that had been collected in specific regions of the Democratic Republic of the Congo just weeks or months earlier. The genetic distance between the Kenyan sample and the Congolese samples was so small that it could only be explained by a recent journey, not by years of local evolution. This finding ruled out the possibility of a separate, locally sustained outbreak and confirmed that this was a cross-border importation.

While the virus was genetically very similar to the Congolese strains, the researchers did notice a few small differences. The Kenyan virus carried six specific changes in the proteins that make up its structure, changes that were not present in the older 2007 or 2012 outbreaks. Because there are no licensed vaccines or treatments for this virus, these small variations are important to track. They could potentially affect how well current diagnostic tests work or how future vaccines might need to be designed. The study authors noted that while these changes were present, they did not alter the fundamental conclusion that the virus had traveled from the Democratic Republic of the Congo.

This single case report provides a vital piece of the puzzle for managing the 2026 outbreak. It demonstrates that the virus is capable of moving across international borders, reinforcing the need for coordinated surveillance between neighboring countries. The findings suggest that health responses in Kenya should focus on tracing the travel and contact history of the patient back to the specific regions in the Democratic Republic of the Congo where the virus was circulating, rather than searching for a local source that does not exist. Furthermore, the study highlights the power of sharing genetic data openly and quickly. Because researchers in the Democratic Republic of the Congo and Uganda had been uploading their virus sequences to a public database, the Kenyan team was able to make this comparison in real time. This rapid exchange of information allowed them to confirm the virus's origin and guide public health measures with precision, proving that in the face of a moving threat, the best defense is a shared understanding of the enemy's path.